187 related articles for article (PubMed ID: 5787285)
1. Peripheral vasodilator drugs.
Br Med J; 1969 Jul; 3(5661):38-40. PubMed ID: 5787285
[No Abstract] [Full Text] [Related]
2. Treatment of peripheral arterial insufficiency with inositoli nicotinas (Hexanicit).
Hentzer E
Scand J Clin Lab Invest Suppl; 1967; 99():226-32. PubMed ID: 4862834
[No Abstract] [Full Text] [Related]
3. [Vasodilator drugs and obliterating arterial diseases of the lower extremities].
Larsen OA; Lassen NA
Ugeskr Laeger; 1967 Sep; 129(36):1168-71. PubMed ID: 5598859
[No Abstract] [Full Text] [Related]
4. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases].
Giulini SM; Agus GB; De Cristoforo A
Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376
[No Abstract] [Full Text] [Related]
5. [Clinical experimentation on the tolerance and efficacy of Lamuran administered by phleboclysis in 39 patients with peripheral vascular diseases].
Dotti GC
Minerva Med; 1973 May; 64(34):1821-30. PubMed ID: 4719379
[No Abstract] [Full Text] [Related]
6. [The vasoactivogram in the treatment of peripheral arteriopathies].
Romeo S; Spinella G; Sciacchitanto D
Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
[No Abstract] [Full Text] [Related]
7. Vasodilator drugs and peripheral vascular disease.
Drug Ther Bull; 1972 Nov; 10(23):91-2. PubMed ID: 4144248
[No Abstract] [Full Text] [Related]
8. [The role of adrenergic stimulation in myocardial ischemia and its correction with beta-blocking agents].
Invernizzi G; Lussana S
Minerva Cardioangiol; 1967 Jul; 15(7):475-80. PubMed ID: 5615131
[No Abstract] [Full Text] [Related]
9. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
Hansteen V; Lorentsen E
Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
[No Abstract] [Full Text] [Related]
10. [Naphydrefuryl, a peripheral vasidolator agent].
Sicard A; Mathivat A; Welti JJ; Perrin A; Natali J; Ranglaret A; Cristol R; Fontaine L; Battino J
Presse Med (1893); 1968 Apr; 76(21):1015-6. PubMed ID: 5655976
[No Abstract] [Full Text] [Related]
11. [Vasodilation caused by inhibition of calcium ions as a factor of increasing oxygen transport in peripheral vascular diseases].
Pola P; Savi L; Dal Lago A; Zucchiatti V
Clin Ter; 1977 Jun; 81(5):417-31. PubMed ID: 884936
[No Abstract] [Full Text] [Related]
12. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
Gore J; Silver R
Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
[No Abstract] [Full Text] [Related]
13. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
Bock KJ
Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
[No Abstract] [Full Text] [Related]
14. Vasodilators: minoxidil and drugs used in peripheral vascular and cerebral disorders.
Lowe GD
Br Med J (Clin Res Ed); 1983 Apr; 286(6373):1262-4. PubMed ID: 6404416
[No Abstract] [Full Text] [Related]
15. [The peripheral blood flow after vasodilatating procedures].
Landgard H
Nord Med; 1971 Jun; 85(22):696. PubMed ID: 5088271
[No Abstract] [Full Text] [Related]
16. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
Bagliani A; Borri P; Taborelli R
Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
[No Abstract] [Full Text] [Related]
17. [Intermittent claudication].
Ibsen B
Ugeskr Laeger; 1992 Aug; 154(35):2377. PubMed ID: 1413156
[No Abstract] [Full Text] [Related]
18. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
Buccellato C; Di Lorenzo GD
Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
[No Abstract] [Full Text] [Related]
19. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
[No Abstract] [Full Text] [Related]
20. The effect of nicotinic acid on muscle blood flow in intermittent claudication measured with xenon-133 clearance method.
Broomé A; Cederlund J; Eklöf B
Scand J Clin Lab Invest Suppl; 1967; 99():233-40. PubMed ID: 4862835
[No Abstract] [Full Text] [Related]
[Next] [New Search]
